Report
EUR 13.78 For Business Accounts Only

An unfavourable environment weighs on INTEGER HOLDINGS, which sees a downgrade to Slightly Negative

The independent financial analyst theScreener just requalified the general evaluation of INTEGER HOLDINGS (US), active in the Medical Equipment industry. As regards its fundamental valuation, the title still shows 1 out of 4 stars and its market behaviour is seen as moderately risky. theScreener believes that the unfavourable environment weighs on the sector and penalises the company, which sees a downgrade to its general evaluation to Slightly Negative. As of the analysis date November 30, 2021, the closing price was USD 79.74 and its target price was estimated at USD 75.75.
Underlying
Integer Holdings Corporation

Integer Holdings is a medical device outsource manufacturing company. The company provides medical technologies and develops batteries for applications in energy, military, and environmental markets. The company's brands include Greatbatch Medical?, Lake Region Medical? and Electrochem?. The company organizes its business into two reportable segments, Medical and Non-Medical, and derive its sales from four principle product lines. The Medical segment includes the Cardio & Vascular, Cardiac & Neuromodulation and Advanced Surgical, Orthopedics & Portable Medical product lines and the Non-Medical segment is comprised of the Electrochem product line.

Provider
TheScreener
TheScreener

Empowering Investors

theScreener is the market leader for independent valuations of financial securities, equities, sectors and markets, and new funds. theScreener's ratings, analyses are used by leading banks, asset managers and financial portals.  Approximately 10,000 workstations benefit from theScreener's services, with over millions of customer accounts actively analysed.

  • Worldwide coverage: theScreener analyses cover around 6'500 Stocks, i.e 95% of the world Market Capitalization.  theScreener state of art: We provide
  • theScreener state of art: We provide easy to use and complete analyses over Stocks, including Fundamentals / Technical / Risk/ Peer / Alternatives analyses.
  • For Research Pool community, we provide twice a week around 500 new equity analyses. We produce analyses about equities which have been upgraded or downgraded

 

Other Reports on these Companies
Other Reports from TheScreener

ResearchPool Subscriptions

Get the most out of your insights

Get in touch